# Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers

> **NCT02329353** · PHASE3 · COMPLETED · sponsor: **Next Gen Pharma India Pvt. Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Chronic Periodontitis

## Interventions

- **DRUG:** Lactobacillus brevis CD2 Lozenges

## Key facts

- **NCT ID:** NCT02329353
- **Lead sponsor:** Next Gen Pharma India Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02329353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02329353, "Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02329353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
